Traditionally, subcutaneous immunotherapy (SCIT) is used in controlling the allergic rhinitis (AR). However, in recent years, interest in sublingual immunotherapy (SLIT) has grown considerably. In this regard, this article gives a brief overview of the safety of SCIT and SLIT for AR and will highlight the similarities and differences and related to these two immunotherapy techniques. Treatment for AR AR is defined as inflammation of the nasal mucosa manifested clinically with symptoms of nasal congestion, rhinorrhea, nasal itching, and sneezing.
Airborne environmental allergens trigger nasal symptoms that include ocular symptoms like pruritus, edema, conjunctival injection etc. The diagnosis of AR typically includes skin-prick testing, analyzing the medical history, and performing physical examination. Treatment of AR can be divided into three categories: allergen avoidance,…
